Roughly 80% of repurchase behavior comes down to one thing: sensory appeal. Not price, not packaging, not the claims on the front of the pack — whether the product tastes and feels right the second time someone eats it. That number is why a failed sensory panel isn't a delay on an alt-protein launch — it's usually the launch's only shot, and most R&D teams are burning that shot with generalist food scientists instead of the sensory scientists and flavor-masking specialists wh

An empty executive office represents the vacant VP of R&D seat stalling food manufacturing leadership decisions and reformulation launch timelines. A vacant R&D leadership seat costs a food and beverage company far more than the unpaid salary line suggests — recent data puts the fully loaded cost of an unfilled executive role at up to 213% of annual salary once lost strategic direction, team drag, and stalled initiatives are counted, and that's before factoring in what the va

Reformulation has become the defining R&D mandate of the decade. GLP-1-driven demand for "better-for-you" products, FDA's 2028 "healthy" claim deadline, and alt-protein sensory failures are all colliding on the same R&D benches at once. Most companies chasing a stalled launch don't actually have an ingredient problem — they have an empty seat problem. The fastest way to protect a launch timeline in 2026 is sourcing the specialized formulation and R&D talent a generalist recru

The GLP-1 product reformulation talent gap is delaying "better-for-you" launches because the scientists who can build high-protein, high-satiety, nutrient-dense products in smaller portions without sacrificing taste and texture are a narrow, largely passive talent pool — and most R&D teams don't have one on staff. Companies sourcing nutrient density and satiety formulation specialists through a specialized food and beverage recruiter are getting these products to shelf faster